MeCP2 expression in human cerebral cortex and lymphoid cells: immunochemical characterization of a novel higher-molecular-weight form.

about

Detecting autonomic response to pain in Rett syndrome.Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands.

P2860

Q38954448-65A23AB8-462F-4F15-9D1C-4839B62F4320 Q40036997-9FFA7138-6F0A-4C09-8256-55C27DE995D2

P2860

MeCP2 expression in human cerebral cortex and lymphoid cells: immunochemical characterization of a novel higher-molecular-weight form.

Item

http://www.wikidata.org/entity/Q47358419

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

MeCP2 expression in human cere ...... higher-molecular-weight form.

@en

MeCP2 expression in human cere ...... higher-molecular-weight form.

@nl

type

Item

label

MeCP2 expression in human cere ...... higher-molecular-weight form.

@en

MeCP2 expression in human cere ...... higher-molecular-weight form.

@nl

prefLabel

MeCP2 expression in human cere ...... higher-molecular-weight form.

@en

MeCP2 expression in human cere ...... higher-molecular-weight form.

@nl

P1476

MeCP2 expression in human cere ...... l higher-molecular-weight form

@en

P2093

Charles G Danko

http://www.w3.org/2001/XMLSchema#string

Genila Bibat

http://www.w3.org/2001/XMLSchema#string

Sriram Reddy

http://www.w3.org/2001/XMLSchema#string

Walter E Kaufmann

http://www.w3.org/2001/XMLSchema#string

Ye-Jin M Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation

Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?

Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome

Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation

MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin

Experience-dependent decrease in synaptically localized Fra-1

Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome

Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.

Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system.

Methyl-CpG-binding proteins. Targeting specific gene repression.

P304

675-682

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/08830738030180101001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M H Jarrar

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8980876

http://www.w3.org/2001/XMLSchema#string

P698

14649548

http://www.w3.org/2001/XMLSchema#string

MeCP2 expression in human cerebral cortex and lymphoid cells: immunochemical characterization of a novel higher-molecular-weight form.

about

P2860

P2860

MeCP2 expression in human cerebral cortex and lymphoid cells: immunochemical characterization of a novel higher-molecular-weight form.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698